BDZ-P7
BDZ-P7 inhibits AMPA receptor GluA2, GluA1/2, GluA2/3, and GluA1 subunit with IC50s of 3.03 μM, 3.14 μM, 3.19 μM, 3.2 μM. BDZ-P7 has neuroprotective effect and reinstates locomotor abilities in a mouse model of Parkinson’s disease[1].
Product Specifications
UNSPSC
12352005
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bdz-p7.html
Smiles
CC(C(NC1=C(OC)C=C(Cl)C(OC)=C1)=O)CC2=CC(OCO3)=C3C=C2
Molecular Formula
C19H20ClNO5
Molecular Weight
377.82
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-161665/BDZ-P7-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-161665/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
AMPA Receptor
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human GNS sgRNA gene knockout kit - Lentiviral human GNS sgRNA gene knockout kit (plasmid)